drugset / Trial / NCT06247046

A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D

NCT06247046 ↗

Phase 3 Recruiting 1298 enrolled Guangzhou Zhiyi Biotechnology Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Live SK08 Powder compared with placebo in the treatment of participants with irritable bowel syndrome with diarrhea.

Timeline

Start
2024-03-16
Primary completion
2026-04
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject SK08 Other / unclassified — Oral